ADPT vs MSFT: Which Stock is Better?
Side-by-side comparison of Adaptive Biotechnologies Corp and Microsoft Corp in 2026
ADPT
Adaptive Biotechnologies Corp
$17.87
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ADPT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.73B | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 1.0% | 14.9% | MSFT |
| Gross Margin | 65.1% | 68.8% | MSFT |
Analyze ADPT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADPT or MSFT a better investment?
Comparing ADPT and MSFT: Adaptive Biotechnologies Corp has a market cap of $2.73B while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADPT and MSFT?
ADPT (Adaptive Biotechnologies Corp) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADPT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADPT or MSFT?
MSFT has higher revenue growth at 14.9% vs 1.0% for ADPT.
Which company is more profitable: ADPT or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 65.1% for ADPT.
Which is the larger company: ADPT or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $2.73B for ADPT.
Should I buy ADPT or MSFT in 2026?
Both ADPT and MSFT have investment merit. ADPT trades at $17.87 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADPT and MSFT stock?
Key differences: Market Cap ($2.73B vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (1.0% vs 14.9%), Gross Margin (65.1% vs 68.8%).